NFH
SVA

NEXT Financial Holdings’s Sinovac Biotech, Ltd SVA Stock Holding History

NEXT Financial Holdings’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$0 Buy
+16
New +$105 ﹤0.01% 1720

Other funds holding SVA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NEXT Financial Holdings's SVA Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Sinovac Biotech, Ltd (SVA) in Q1 2019: 16 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1720 among its holdings.

25 funds tracked by Wall St. Rank hold SVA as of Q1 2019.

  • NEXT Financial Holdings held 16 shares of Sinovac Biotech, Ltd worth $0 as of Q1 2019.
  • Sinovac Biotech, Ltd was a new NEXT Financial Holdings position in Q1 2019.
  • Sinovac Biotech, Ltd made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1720 holding.
  • 25 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.